Psychedelic Drugs Market Report Highlights Growth at 13 Percent CAGR by 2030

The 𝐏𝐬𝐲𝐜𝐡𝐞𝐝𝐞𝐥𝐢𝐜 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 was valued at USD 5.50 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 58%, reaching approximately USD 12.94 billion by 2030. This growth reflects the increasing acceptance and adoption of psychedelic drugs in treating various mental health conditions.

𝐏𝐬𝐲𝐜𝐡𝐞𝐝𝐞𝐥𝐢𝐜 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:

Psychedelic drugs, which include substances such as DMT, ketamine, LSD, MDMA, psilocybin, and GHB, are increasingly being recognized for their therapeutic potential, especially in treating mental health disorders like depression, PTSD, and addiction. These drugs are utilized both independently and in combination with traditional therapies to improve patients' mental well-being. The market is gaining traction as new drugs are developed and as public awareness and regulatory acceptance of psychedelics for medical use increase. Additionally, the growing shift towards digital healthcare solutions and the rise of clinical studies and government-backed initiatives are fueling market growth.

𝐖𝐚𝐧𝐭 𝐭𝐨 𝐒𝐞𝐞 𝐭𝐡𝐞 𝐓𝐫𝐞𝐧𝐝𝐬? 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐚 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐓𝐨𝐝𝐚𝐲:https://www.stellarmr.com/report/req_sample/Psychedelic-Drugs-Market/296 

𝐃𝐫𝐢𝐯𝐞𝐫𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐏𝐬𝐲𝐜𝐡𝐞𝐝𝐞𝐥𝐢𝐜 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭:

The growth of the Psychedelic Drugs Market is driven by several key factors, including the rising demand for effective treatments for mental health disorders such as depression, PTSD, and addiction. The increasing awareness of the therapeutic benefits of psychedelic drugs, particularly in treating conditions that are resistant to traditional treatments, is further propelling market growth. Moreover, the market benefits from the expanding acceptance of psychedelics within the medical community and growing government support for clinical trials and research. The development of novel formulations and treatment methods, such as psilocybin for mental health conditions, is also contributing to the demand for psychedelic drugs.

𝐏𝐬𝐲𝐜𝐡𝐞𝐝𝐞𝐥𝐢𝐜 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐫𝐞𝐧𝐝𝐬:

A notable trend in the Psychedelic Drugs Market is the shift towards incorporating psychedelics in clinical settings for the treatment of mental health disorders. The use of psychedelic substances, such as ketamine and psilocybin, in controlled therapeutic environments is gaining traction, with an increasing number of clinical trials demonstrating their efficacy. Furthermore, the growing acceptance of digital health platforms that integrate psychedelic therapies and the increasing demand for personalized treatment plans are expected to expand the market. Additionally, as more countries and regions move towards legalizing psychedelics for therapeutic use, the market is expected to experience significant growth in the coming years.

𝐓𝐡𝐞 𝐈𝐧𝐭𝐞𝐫𝐞𝐬𝐭𝐞𝐝 𝐒𝐭𝐚𝐤𝐞𝐡𝐨𝐥𝐝𝐞𝐫𝐬 𝐜𝐚𝐧 𝐈𝐧𝐪𝐮𝐢𝐫𝐞 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:https://www.stellarmr.com/report/enquire_now/Psychedelic-Drugs-Market/296

𝐌𝐞𝐫𝐠𝐞𝐫𝐬 𝐚𝐧𝐝 𝐀𝐜𝐪𝐮𝐢𝐬𝐢𝐭𝐢𝐨𝐧𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐏𝐬𝐲𝐜𝐡𝐞𝐝𝐞𝐥𝐢𝐜 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐆𝐥𝐨𝐛𝐚𝐥 𝐔𝐩𝐝𝐚𝐭𝐞𝐬

𝐆𝐫𝐨𝐰𝐭𝐡 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬 𝐢𝐧 𝐕𝐢𝐞𝐭𝐧𝐚𝐦

Vietnam's psychedelic drugs market is gaining traction as mental health awareness grows. Vietnam Biopharma Ltd. partnered with international research organizations to study the therapeutic potential of psilocybin and MDMA for PTSD and depression. Governmental support for modern mental health initiatives is driving the adoption of innovative therapies.

𝐓𝐫𝐞𝐧𝐝𝐬 𝐢𝐧 𝐓𝐡𝐚𝐢𝐥𝐚𝐧𝐝

Thailand is experiencing a gradual increase in the adoption of psychedelic-assisted therapies, particularly for anxiety and addiction. Thai Wellness Innovations launched a clinical program in 2023 to explore psilocybin-based treatments for substance abuse. Regulatory advancements promoting mental health research are fostering market growth.

𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐲 𝐆𝐫𝐨𝐰𝐭𝐡 𝐢𝐧 𝐉𝐚𝐩𝐚𝐧

Japan remains a hub for innovative mental health solutions, leveraging its advanced pharmaceutical capabilities. Companies like Otsuka Pharmaceutical Co., Ltd. invested in clinical trials exploring the potential of ketamine and psilocybin. Rising societal focus on reducing stigma around mental health disorders is boosting market demand.

𝐂𝐨𝐧𝐬𝐨𝐥𝐢𝐝𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐒𝐨𝐮𝐭𝐡 𝐊𝐨𝐫𝐞𝐚

South Korea's psychedelic drugs market is undergoing consolidation as major firms acquire biotech startups focused on psychedelic research. Korea NeuroHealth Ltd. acquired Seoul PsyBioTech, expanding its portfolio in mental health therapies. The growing prevalence of stress-related disorders is shaping market trends.

𝐔𝐩𝐝𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐒𝐢𝐧𝐠𝐚𝐩𝐨𝐫𝐞

Singapore's psychedelic drugs market is advancing with a focus on precision medicine and data-driven research. Singapore Health Sciences Institute collaborated with European biotech firms to conduct large-scale studies on psychedelic therapies. Government policies supporting biomedical innovation are fostering growth.

𝐆𝐫𝐨𝐰𝐭𝐡 𝐢𝐧 𝐭𝐡𝐞 𝐔𝐧𝐢𝐭𝐞𝐝 𝐒𝐭𝐚𝐭𝐞𝐬

The United States remains a leading market for psychedelic drugs, driven by significant investments in clinical research and progressive state-level legalization. Compass Pathways and MAPS led groundbreaking studies on MDMA and psilocybin in 2023, targeting PTSD and depression. Federal funding for mental health research is propelling market expansion.

𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬 𝐢𝐧 𝐄𝐮𝐫𝐨𝐩𝐞

Europe's psychedelic drugs market is thriving, supported by increasing acceptance of alternative mental health treatments and favorable regulatory policies. Companies such as MindMed and Atai Life Sciences are leading innovations in psychedelic-assisted therapy. The European Union's focus on comprehensive mental health care is driving substantial investments.

𝐊𝐞𝐲 𝐑𝐞𝐜𝐞𝐧𝐭 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬

Vietnam Biopharma Ltd. collaborated with global partners to advance research on psilocybin and MDMA.

Thai Wellness Innovations launched a psilocybin-based clinical program for addiction treatment.

Otsuka Pharmaceutical Co., Ltd. invested in ketamine and psilocybin trials targeting Japanese patients.

Korea NeuroHealth Ltd. acquired Seoul PsyBioTech, consolidating its market position in South Korea.

Singapore Health Sciences Institute initiated large-scale psychedelic studies in partnership with European biotech firms.

Compass Pathways and MAPS advanced clinical trials on MDMA and psilocybin in the United States.

MindMed and Atai Life Sciences expanded their portfolios with innovative psychedelic-assisted therapies in Europe.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐮𝐥𝐥 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 @https://www.stellarmr.com/report/req_sample/Psychedelic-Drugs-Market/296

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐏𝐬𝐲𝐜𝐡𝐞𝐝𝐞𝐥𝐢𝐜 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭:

by Product

DMT
Ketamine
LSD
MDMA
GHB
Psilocybin
Others

by Disease Indication

Depression
PTSD
Drug & Alcohol dependence
Others

by Route of Administration

Oral
Intranasal
Intravenous

by Distribution Channel

Online Pharmacies
Hospital Pharmacies
Retail pharmacies

𝐅𝐨𝐫 𝐦𝐨𝐫𝐞 𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 𝐚𝐛𝐨𝐮𝐭 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐯𝐢𝐬𝐢𝐭:https://www.stellarmr.com/report/Psychedelic-Drugs-Market/296

𝐖𝐡𝐨 𝐢𝐬 𝐭𝐡𝐞 𝐥𝐚𝐫𝐠𝐞𝐬𝐭 𝐦𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐞𝐫𝐬 𝐨𝐟 𝐏𝐬𝐲𝐜𝐡𝐞𝐝𝐞𝐥𝐢𝐜 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐰𝐨𝐫𝐥𝐝𝐰𝐢𝐝𝐞?

The Emmes Company (United States)
AstraZeneca (United Kingdom)
F. Hoffmann-La Roche Ltd (Switzerland)
Dr. Reddy's Laboratories Ltd (Hyderabad)
Takeda Pharmaceutical Company Limited (Japan)
Pfizer Inc. (United States)
Mylan N.V. (United States)
Merck & Co., Inc. (United States)
Alkermes (Ireland)
ALLERGAN (Ireland)
H. Lundbeck A/S (Denmark)
Mota Ventures Corp. (Canada)
Janssen Pharmaceuticals (Belgium)
Hikma Pharmaceuticals PLC (United Kingdom)
Avadel (Ireland)
Celon Pharma S.A (Poland)

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐒𝐭𝐞𝐥𝐥𝐚𝐫 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

♦ Outdoor Heating Market https://www.stellarmr.com/report/Outdoor-Heating-Market/786
♦ Pup Joint Market https://www.stellarmr.com/report/Pup-Joint-Market/849
♦ General Machinery Bearings Market https://www.stellarmr.com/report/General-Machinery-Bearings-Market/1044
♦ CNC Polishing Machine Market https://www.stellarmr.com/report/CNC-Polishing-Machine-Market/1046
♦ Green Packaging Market https://www.stellarmr.com/report/Green-Packaging-Market/513

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐒𝐭𝐞𝐥𝐥𝐚𝐫 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

S.no.8, h.no. 4-8 Pl.7/4, Kothrud,

Pinnac Memories Fl. No. 3, Kothrud, Pune,

Pune, Maharashtra, 411029

sales@stellarmr.com

𝐀𝐛𝐨𝐮𝐭 𝐒𝐭𝐞𝐥𝐥𝐚𝐫 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

Stellar Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include science and engineering, electronic components, industrial equipment, technology, and communication, cars, and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

This release was published on openPR.